Much has been written about the epidemic of preventable limb loss in the United States. When we say “preventable” limb loss, of course, we’re largely referring to limb loss that occurs as a complication of Type 2 diabetes or peripheral artery disease. Those conditions account for roughly half of all amputations in the United States, as we know from the Amputee Coalition’s new prevalence study, and the trend has persisted for decades despite some high-profile efforts to bend the curve.
